USA - NASDAQ:AIFF - US3179701012 - Common Stock
The current stock price of AIFF is 1.63 USD. In the past month the price decreased by -36.5%. In the past year, price decreased by -45.28%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 39.49 | 48.22B | ||
| DOCS | DOXIMITY INC-CLASS A | 30.81 | 9.47B | ||
| WAY | WAYSTAR HOLDING CORP | 27.19 | 6.95B | ||
| HTFL | HEARTFLOW INC | N/A | 2.63B | ||
| PHR | PHREESIA INC | N/A | 1.37B | ||
| CERT | CERTARA INC | 17.58 | 1.41B | ||
| SDGR | SCHRODINGER INC | N/A | 1.30B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.28B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.07B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | 625 | 1.06B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 8.79 | 1.07B | ||
| CTEV | CLARITEV CORP | N/A | 781.01M |
Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company, which engages in developing neuroscientific solutions for mental illnesses and neurological disorders. The company is headquartered in Kenmore, New York and currently employs 13 full-time employees. The firm has developed its FDA-510(k) cleared Brain Network Analytics software platform (the BNA Platform) and is focused on advancing diagnostic and treatment approaches for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. The firm's Brain Network Analytics is a neurophysiological assessment tool that uses artificial intelligence and machine learning to analyze electroencephalogram (EEG) data recorded during rest and cognitive activity. The BNA Platform, in conjunction with an EEG system, provides clinicians with comprehensive insights into brain function (cognition).
FIREFLY NEUROSCIENCE INC
1100 Military Road
Kenmore NEW YORK US
Employees: 13
Phone: 18882376412
Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company, which engages in developing neuroscientific solutions for mental illnesses and neurological disorders. The company is headquartered in Kenmore, New York and currently employs 13 full-time employees. The firm has developed its FDA-510(k) cleared Brain Network Analytics software platform (the BNA Platform) and is focused on advancing diagnostic and treatment approaches for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. The firm's Brain Network Analytics is a neurophysiological assessment tool that uses artificial intelligence and machine learning to analyze electroencephalogram (EEG) data recorded during rest and cognitive activity. The BNA Platform, in conjunction with an EEG system, provides clinicians with comprehensive insights into brain function (cognition).
The current stock price of AIFF is 1.63 USD. The price decreased by -6.32% in the last trading session.
AIFF does not pay a dividend.
AIFF has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
AIFF stock is listed on the Nasdaq exchange.
FIREFLY NEUROSCIENCE INC (AIFF) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.93).
FIREFLY NEUROSCIENCE INC (AIFF) has a market capitalization of 21.92M USD. This makes AIFF a Nano Cap stock.
ChartMill assigns a fundamental rating of 1 / 10 to AIFF. While AIFF seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months AIFF reported a non-GAAP Earnings per Share(EPS) of -2.93. The EPS decreased by -59.54% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -182.4% | ||
| ROE | -225.18% | ||
| Debt/Equity | 0 |